IntrinsicIntrinsic
← Scroll for more →

Financial Statements — MDCX

Balance Sheet

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Cash & Equivalents15.176.378.718.669.673.984.16
Total Current Assets16.987.289.899.7811.005.095.38
Total Non-current Assets*10.130.140.170.200.940.570.27
Total Assets27.127.4310.069.9811.935.665.65
Accounts Payable0.311.041.001.561.831.060.76
Short-term Debt--2.345.256.794.70----
Total Current Liabilities10.845.959.9410.668.543.342.31
Total Non-current Liabilities*18.000.050.090.120.140.170.21
Total Liabilities28.846.0010.0210.788.693.512.51
Retained Earnings(85.01)(73.39)(64.35)-0.00(40.18)(34.01)(28.90)
Total Stockholder Equity*(1.76)1.33(0.07)(0.91)3.252.153.13
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Research & Development4.912.702.591.681.442.011.37
Selling, General & Admin6.575.8910.220.004.583.122.22
Total Operating Expenses11.488.6023.220.006.025.133.59
Operating Income(11.48)(8.60)(23.22)-0.00(6.02)(5.13)(3.59)
Interest Expense0.210.37----------
Net Income(11.62)(9.04)(15.07)(20.94)(3.63)(5.10)(3.54)
Basic EPS(0.21)(0.31)(38.50)(1.12)(0.43)(0.42)(13.50)
Diluted EPS(0.21)(0.31)(38.50)(1.12)(0.43)(0.42)(13.50)
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025
Operating Cash Flow(6.98)(8.97)(6.61)(6.76)(5.47)(3.94)
Investing Cash Flow------(4.62)----
Financing Cash Flow25.536.836.6510.3711.163.76
← Scroll for more columns →